Tumor antigen

Tumor antigen

Tumor antigen is a substance produced in tumor cells that triggers an immune response in the host. Tumor antigens are useful in identifying tumor cells and are potential candidates for use in cancer therapy.

Mechanism of tumor antigenesis

Normal proteins in the body are not antigenic because of self-tolerance, a process in which self-reacting cytotoxic T lymphocytes (CTLs) and autoantibody-producing B lymphocytes are culled in the thymus. Thus any protein that is not exposed to the immune system triggers an immune response. This may include normal proteins that are well sequestered from the immune system, proteins that are normally produced in extremely small quantities, proteins that are normally produced only in certain stages of development, or proteins whose structure is modified due to mutation.

Classification of Tumor Antigens

Initially they were broadly classified into two categories based on their pattern of expression: Tumor-Specific Antigens, "which are present only on tumor cells and not on any other cell" and Tumor-Associated Antigens, "which are present on some tumor cells and also some normal cells"

This classification, however,is imperfect because many antigens thought to be "tumor-specific" turned out to be expressed on some normal cells as well. The "modern classification" of tumor antigens is based on their molecular structure and source.

Accordingly they can be classified as;

1. Products of Mutated Oncogenes and Tumor Suppressor Genes
2. Products of Other Mutated Genes
3. Overexpressed or Aberrantly Expressed Cellular Proteins
4. Tumor Antigens Produced by Oncogenic Viruses
5. Oncofetal Antigens
6. Altered Cell Surface Glycolipids and Glycoproteins
7. Cell Type-Specific Differentiation Antigens

Types

Any protein produced in a tumor cell that has an abnormal structure due to mutation can act as a tumor antigen. Such abnormal proteins are produced due to mutation of the concerned gene. Mutation of protooncogenes and tumor suppressors which lead to abnormal protein production are the cause of the tumor and thus such abnormal proteins are called tumor-"specific" antigens. Examples of tumor-specific antigens include the abnormal products of ras and p53 genes. In contrast, mutation of other genes unrelated to the tumor formation may lead to synthesis of abnormal proteins which are called tumor-"associated" antigens.

Proteins that are normally produced in very low quantities but whose production is dramatically increased in tumor cells, trigger an immune response. An example of such a protein is the enzyme tyrosinase, which is required for melanin production. Normally tyrosinase is produced in minute quantities but its levels are very much elevated in melanoma cells.

Oncofetal antigens are another important class of tumor antigens. Examples are alphafetoprotein (AFP) and carcinoembryonic antigen (CEA). These proteins are normally produced in the early stages of embryonic development and disappear by the time the immune system is fully developed. Thus self-tolerance does not develop against these antigens.

Abnormal proteins are also produced by cells infected with oncoviruses, eg. EBV and HPV. Cells infected by these viruses contain latent viral DNA which is transcribed and the resulting protein produces an immune response.

In addition to proteins, other substances like cell surface glycolipids and glycoproteins may also have an abnormal structure in tumor cells and could thus be targets of the immune system.

Importance of tumor antigens

Tumor antigens, because of their relative abundance in tumor cells are useful in identifying specific tumor cells. Certain tumors have certain tumor antigens in abundance.

Certain tumor antigens are thus used as tumor markers. More importantly, tumor antigens can be used in cancer therapy as tumor antigen vaccines. [ M Hareuveni, C Gautier, M Kieny, D Wreschner, P Chambon and R Lathe; [http://www.pnas.org/cgi/content/abstract/87/23/9498 Vaccination Against Tumor Cells Expressing Breast Cancer Epithelial Tumor Antigen] ; "Proceedings of the National Academy of Sciences", Vol 87, 9498-9502, 1990. ]

See also

* Antigen
* Tumor marker
* Cancer immunotherapy

References

* Kumar, Abbas, Fausto; "Robbins and Cotran: Pathologic Basis of Disease"; Elsevier, 7th ed.
* Coulie PG, Hanagiri T, Takanoyama M: From Tumor Antigens to Immunotherapy. Int J Clin Oncol 6:163, 2001.

External links

* [http://www.ncbi.nlm.nih.gov/books/bv.fcgi?highlight=tumor,antigen&rid=cmed6.chapter.3617 Chapter on tumor antigens in Cancer Medicine at NCBI]


Wikimedia Foundation. 2010.

Игры ⚽ Нужно решить контрольную?

Look at other dictionaries:

  • Tumor antigen vaccine — A tumor antigen vaccine is a vaccine made of cancer cells, parts of cancer cells, or pure tumor antigens (substances isolated from tumor cells). A tumor antigen vaccine may stimulate the body s immune system to find and kill cancer cells.… …   Wikipedia

  • tumor antigen vaccine — A vaccine made of cancer cells, parts of cancer cells, or pure tumor antigens (substances isolated from tumor cells). A tumor antigen vaccine may stimulate the body s immune system to find and kill cancer cells …   English dictionary of cancer terms

  • tumor antigen — 1. T a. (def. 1). 2. tumor specific a. 3. tumor associated a …   Medical dictionary

  • Tumor marker — A tumor marker is a substance found in the blood, urine, or body tissues that can be elevated in cancer, among other tissue types. There are many different tumor markers, each indicative of a particular disease process, and they are used in… …   Wikipedia

  • Antigen-Shedding — Schematische Darstellung des Antigen Sheddings mit einer ADAM Metalloproteasen. Unter dem Begriff Antigen Shedding versteht man in der Immunologie das Abstoßen von Antigenen von der Zellmembran von Körperzellen. Der Begriff wird vor allem in der… …   Deutsch Wikipedia

  • Tumor-associated calcium signal transducer 1 — Tumor associated calcium signal transducer 1, also known as TACSTD1, is a human gene.cite web | title = Entrez Gene: TACSTD1 tumor associated calcium signal transducer 1| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene Cmd=ShowDetailView… …   Wikipedia

  • Tumor M2-PK — is a synonym for the dimeric form of the pyruvate kinase isoenzyme type M2 (PKM2).Tumor M2 PK is a key enzyme within tumor metabolism and can be used in stool (fecal) samples for the screening of colorectal tumors (= bowel cancer) and in EDTA… …   Wikipedia

  • Antigen presentation — is a process in the body s immune system by which macrophages, dendritic cells and other cell types capture antigens and then enable their recognition by T cells. NOTOC The basis of adaptive immunity lies in the capacity of immune cells to… …   Wikipedia

  • Tumor necrosis factor-alpha — Tumor necrosis factor (TNF, cachexin or cachectin and formally known as tumor necrosis factor alpha ) is a cytokine involved in systemic inflammation and is a member of a group of cytokines that all stimulate the acute phase reaction. TNF causes… …   Wikipedia

  • Antigen — Each antibody binds to a specific antigen; an interaction similar to a lock and key. An antigen is a foreign molecule that, when introduced into the body, triggers the production of an antibody by the immune system. The immune system will then… …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”